axicabtagene ciloleucel,tisagenlecleucel
daiichi sankyo,pfizer,novartis,gilead
['axi-cel', 'tisa-cel', 'lymphoma', ' axi ']
scholar-1 refractoriness criteria influence car-t efficacy! in the spanish experience presented by axi showed better results than tisa in
terms of efficacy, but also significantly more early toxicity real world data from #lymphoma #ash22 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes